Key facts
- Noah Labs’s last known valuation is $1.1M (Jan 2022).
- It has raised $3.4M; the latest was Early Stage VC in Dec 2025.
- Notable investors include Creative Destruction Lab, European Innovation Council, Entrepreneurs First, LvlUp Ventures, JVH Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Noah Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Noah Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Noah Labs
Developer of software-based medical devices designed to offer voice-based machine learning software for the early detection of heart failure. The company's digital health platform includes patient monitoring and digital biomarkers and utilizes novel technology to deliver personalized and predictive virtual care at home, enabling patients to live longer and happier lives despite their cardiovascular condition.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2021
- Employees
- 23
- Website
- noah-labs.com/
- Ownership
- Privately Held (backing)
Noah Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Noah Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Noah Labs in its N-PORT filings yet. We sweep new filings monthly.